U.K. Advocacy Groups Consider Legal Action Against Pharma Trade Agreement
Two advocacy groups are urging the U.K. government to reconsider regulations tied to a U.S. pharma trade deal, threatening legal action if changes are not made.
Concerns Rise as Americans in Congo May Have Been Exposed to Ebola
Several Americans currently in the Congo are thought to have been exposed to suspected Ebola cases amid the ongoing outbreak in the region.
Exploring the Health Risks of Rare Earth Ions: A Study on Cytotoxicity and Toxicity Prediction
A recent study published in ACS Publications examines the health risks posed by rare earth ions, particularly focusing on their cytotoxic effects and methods for predicting mixed toxicity.
Stranded Humpback Whale 'Timmy' Found Dead Off Denmark, Raising Conservation Concerns
The dead humpback whale, identified as 'Timmy,' highlights ongoing issues regarding marine life conservation in the region after weeks of being stranded.
Izz al-Din al-Haddad, Last Hamas Chief Linked to October 7 Attack, Killed in Air Strike
The recent air strike that resulted in the death of Izz al-Din al-Haddad adds to the tensions surrounding an already fragile ceasefire in the region.
Concerns Grow as FDA Drug Center Head Tracy Beth Høeg Resigns
Tracy Beth Høeg's resignation from the FDA's drug center follows the recent departure of Commissioner Marty Makary, highlighting a troubling leadership gap within the agency.
Recent Changes in the Pharmaceutical Sector: New Hires and Promotions
The pharmaceutical industry is witnessing various changes, including new hires and promotions. Ailux has appointed Maria Belvisi as its chief scientific officer.
Understanding Federal Vaccine Injury Compensation Programs: Key Insights
This editorial explores the federal government's Vaccine Injury Compensation Program and the Countermeasures Injury Compensation Program, highlighting their history and ongoing policy discussions.
Potential Changes in Drug Pricing Amid U.K. Political Contest
The political landscape in the U.K. may influence drug pricing strategies, while the U.S. continues to press Germany for higher drug payments, amidst other health developments.
U.S. Urges Germany to Reconsider Drug Pricing Strategies Amid Ongoing FDA Changes
In the latest Pharmalittle update, the U.S. is applying pressure on Germany regarding drug pricing policies, alongside notable changes within the FDA and developments in biotech clinical trials.
Current Status of Mail-Order Abortion Pills Remains Legal
In recent health news, the legality of mail-order abortion pills persists, while the Africa CDC has announced an Ebola outbreak in the DRC, among other updates.
Collaborative Playlists: A New Way to Stay Connected for Cyclists
Researchers from James Cook University reveal how a collaborative playlist helped cycling enthusiasts maintain social connections during pandemic lockdowns, offering insights into mental health support.
Justice Department Raises Concerns Over Admissions Practices at Yale and UCLA Medical Schools
The DOJ has accused Yale and UCLA medical schools of potentially discriminatory admissions practices against white and Asian applicants, highlighting ongoing debates about equity in education.
Health Politics in Focus: Makary's Exit and Cassidy's Senate Challenges
The latest episode of 'The Readout LOUD' delves into significant health politics, highlighting Marty Makary's recent departure from the FDA and the implications for Senator Cassidy's position.
CDC to Relocate Over 160 Macaques to Texas Sanctuary in Effort to Reduce Animal Testing
In a significant move towards reducing animal testing, the CDC plans to transfer more than 160 macaques to Born Free USA, a nonprofit sanctuary in Texas.
BeOne Secures FDA Approval in Lymphoma Treatment
In a significant development, BeOne has received FDA approval for its lymphoma treatment. Meanwhile, Regenxbio is making strides in Duchenne gene therapy, among other biotech updates.
Exploring the Absence of Major Digital Health Companies in Medicare's ACCESS Pilot
This edition of STAT Health Tech examines the reasons behind the absence of major digital health companies from Medicare's ACCESS pilot program, alongside other industry updates.
Pharmalittle: Highlights from Recent Developments in Medicine
Biogen has shared mixed findings from a mid-stage trial for an Alzheimer’s treatment aimed at the tau protein, amidst other industry news.
Exploring the Future of Medicaid and Public Health Collaborations in 2025
A recent survey sheds light on the evolving partnerships between state Medicaid programs and public health agencies, revealing shared priorities and community health advancements.
Public Confidence in Health Agencies Remains Low, KFF Poll Indicates
A recent KFF Health Tracking Poll shows that many adults lack confidence in the independence of government health agencies responsible for food and drug safety, raising concerns about public health oversight.